What Happened?
Watertown, MA-based Arkuda Therapeutics Appointed Duane Burnett as Chief Technology Officer
Date of management change: April 04, 2023
Watertown, MA-based Arkuda Therapeutics Appointed Duane Burnett as Chief Technology Officer
Arkuda Therapeutics is a biotechnology company applying insights into lysosomal biology to drive the development of medicines to change the trajectory of neurodegenerative disease. Arkuda`s lead program ARKD-104 aims to correct progranulin deficiency and lysosomal dysfunction in patients with GRN-related frontotemporal dementia (FTD-GRN), a genetically-defined subtype of frontotemporal dementia caused by an autosomal dominant mutation in the progranulin (GRN) gene. The company is further exploring the therapeutic potential of its molecules in other neurodegenerative diseases where genetic links to dysfunction in progranulin biology have been established, including Alzheimer`s Disease and Parkinson`s Disease. Arkuda is backed by leading investors including Atlas Venture, Cormorant Asset Management, Pfizer Ventures, funds managed by Tekla Capital Management LLC, Mission BioCapital, and Eli Lilly and Company.
Duane Burnett is Chief Technology Officer at Arkuda Therapeutics. Previously, Duane held various senior IT leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Payne Jim, Young John, Lupowitz Kevin, Steinmetz Joe, Lau Lucas, Korgaonkar Nitin, Willems Steven, Connelly Mark, Parks Delbert, Skytta Timo, Erolin Justice
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.